INSIGHTS ON CLINICAL TRIAL PARTNERING

• Optimizing Clinical Supply Management With A One-Team Approach

  See how NewAmsterdam Pharma managed 11 global studies across 51 countries and 835 sites for 12,000+ patients without overwhelming their internal team.

• Four Pivotal Categories To Elevate Your Clinical Vendor Management

  For sponsors ready to improve vendor management, technology platforms with the right framework can help you tighten budget controls, improve data integrity, or foster collaborative vendor relationships.

• More Than Technology: How People Make The Difference For Customers

  Technology alone doesn’t guarantee success. Here, we explain how integrated processes, skilled teams, and collaborative partnerships complement innovation to reduce risk and improve patient outcomes.

• 5 Common Gaps Between Patient Referral And Screening That Derail Trials

  Up to 40% of clinical trial referrals drop off before screening due to financial, logistical, and administrative hurdles. Streamlining coordination and easing patient burden can boost enrollment.

• When Should You Rescue Your Clinical Trial From A Bad RTSM?

  4/28/2026

  Stop settling for tech delays that drain your team. Learn how to evaluate a mid-study transition and implement a rescue plan that restores efficiency and control to your clinical operations.

• Reducing Inventory Errors In Clinical Trials

  5/8/2026

  Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.

• Considerations For Drug-Device Combination Products In Rare Diseases

  8/7/2025

  The development process for these products is complex, requiring careful consideration of regulatory requirements, technical feasibility, clinical efficacy, and patient-centered design.

• Innovative Approaches In Oncology Clinical Trials

  2/6/2025

  By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.

• Tailored Approach Supports Bladder Cancer Breakthrough

  3/5/2026

  Discover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.